We can treat some of areas of addiction through harm reduction, but we will never be able to fully solve it, until we understand the "why" behind it.
In this episode, we speak with Dr. Michael Miller, CEO of the Miller Care Group, about how his clinical approach to addiction differs from others by drilling down into the root causes and treating addiction as the source.
Key topics:
Views expressed in this material are opinions of the host and the guest, and do not necessarily reflect the views of Rigaku Analytical Devices.
Listen and subscribe on your favorite podcast player:
To make sure you never miss an episode of The Opioid Matrix, subscribe on Apple Podcasts, Spotify, the website, or your favorite podcast player here: https://plinkhq.com/i/1625927161?to=page